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Abstract
The first year of life represents a time of marked susceptibility to infections; this is particularly true for regions in sub-
Saharan Africa. As innate immunity directs the adaptive immune response, the observed increased risk for infection as well
as a suboptimal response to vaccination in early life may be due to less effective innate immune function. In this study, we
followed a longitudinal cohort of infants born and raised in South Africa over the first year of life, employing the most
comprehensive analysis of innate immune response to stimulation published to date. Our findings reveal rapid changes in
innate immune development over the first year of life. This is the first report depicting dramatic differences in innate
immune ontogeny between different populations in the world, with important implications for global vaccination
strategies.
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Introduction
The first year of life represents a time of marked susceptibility to
infections and sub-optimal response to many vaccines [1,2,3]. It
also is a period of important developmental changes in the
immune system [1,2,3,4]. As innate immunity directs the adaptive
immune response following pathogen exposure or vaccination,
and adaptive immune responses have been shown to be largely
functional already early in life [5,6,7], the increased risk for
infectious related morbidity and mortality as well as a suboptimal
response to vaccination could at least be partially due to less
effective innate immune function in neonates and infants as
compared to adults [4,5,6,8,9].
Antigen presenting cells (APC) represent the key link between
the innate and adaptive immune system [10,11]. The major
human APCs are monocytes, classical dendritic cells (cDC) and
plasmacytoid dendritic cells (pDC), as well as B cells. Stimulation
of APCs with pathogen associated molecular patterns (PAMP)
induces antigen presentation, expression of costimulatory mole-
cules and secretion of cytokines by APC that direct the ensuing
adaptive immune response [12]. PAMP are recognized by the
APC via pattern recognition receptors (PRR), of which Toll-like
receptors (TLR) are the best studied example [12]. We previously
developed a stringently controlled high-throughput platform that
enables robust investigation of changes in innate immunity over
time [13,14,15]. Using this platform, we had examined the TLR
response of the four major human APC in a cohort of children
born and raised in North America and found that instead of lower
innate immune responses to TLR stimulation in early life,
strikingly different response patterns exist that dynamically change
over the first 2 years of life [16,17]. These findings were in
agreement with studies of infants born and raised in other
resource-rich settings [18,19].
However, the risk of suffering from and dying of serious
infection in early life is by far the greatest in sub-Saharan Africa
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and other resource-poor regions of the world [20]. In our current
study we prospectively followed a cohort of infants born and raised
in South Africa over the first year of life. Our previously
established comprehensive platform was used to analyze produc-
tion of innate cytokines in key functional categories utilizing both
multiplex bead array and intracellular cytokine cytometric
strategies [13,14,15]. A dynamic development of innate immunity
was identified, which was unique to the population we studied, the
age of the individual, as well as the stimulus employed. Given these
as well as similar previous accounts [21,22,23], it is likely that
dramatic differences in innate immune ontogeny exist between
different populations.
Results
Striking stimulus and age-dependent differences in
secreted cytokine production in response to PRR
stimulation of South African infants’ whole blood within
the first year of life
Stimulation of PRRs with PAMPs allows cells expressing the
relevant receptors to respond with changes in cytokine production
[24]. In Figure 1 and 2 we grouped the 14 cytokines we analyzed
based on their major known functions, i.e. those promoting either
Th1 (IFN-a, IFN-c and IL-12p70, as well as the IFN-c-induced-
protein, IP-10), or Th17 development of CD4 T cells (IL-12p40,
IL-23 and IL-6), those considered to be general pro-inflammatory
or chemoattractant (TNF-a, IL1-b, IL-8, MCP-1, MIP-1a, MIP-
1b) or anti-inflammatory (IL-10).
Only TLR3, TLR7/8 or TLR9 agonists induced production of
the Th1 promoting cytokines IFN-a, IFN-c or IL-12p70 (Figure 1;
Table S1). Specifically, TLR7/8 stimulation with R848 led to
IFN-a secretion in younger infant samples that was significantly
higher compared to the 12 month-old infant and adult samples.
TLR9-induced IFN-a production followed a similar trend, from a
high at 2 weeks to an adult-low by 12 months of age. TLR3-
induced production of IFN-c and IL-12p70 in infant samples at 2
weeks, 6 weeks and 6 months of age was found at levels above
those of adults, with the 12-month samples approaching the adult-
low level. TLR7/8-induced IFN-c production was also highest in
the 2 and 6 week infant samples, but samples from infants 6 and 12
months of age already secreted IFN-c at or below adult samples by
6 months of age. As expected, the production of IP-10 largely
followed the trends of IFN-c, with the notable exception of a peak
around 6 months of age in response to TLR7/8 stimulation.
Production of Th17 promoting cytokines (IL-23 (consisting of
IL-12p40 and p19) and IL-6) occurred in response to a broader
range of stimuli as compared to Th1-promoting cytokines
(Figure 1; Table S1). NOD1/2 & TLR2 stimulation induced high
levels of both IL-23 and IL-6 in infant samples that decreased by
12 months to an adult-low. TLR2/1 activation induced a strong
IL-6 and IL-23 response that followed a similar trend, but did not
induce IL-12p40 above background. TLR3 stimulation led to IL-
23 production in the early infant samples that decreased to an
adult low by 12 months of age yet induced no IL-6 secretion in any
of the age groups tested. The TLR7/8 agonist R848 induced IL-6
secretion that dropped from an early infant high to an adult low by
12 months, but sustained higher levels of IL-23 in infant samples as
compared to adult samples. TLR4 stimulation induced sustained
high IL-6 production, but, contrary to all other trends, an increase
in IL-23 production from a 2 and 6 week low to above adult levels
at 6 and 12 months of age.
Secretion of pro-inflammatory/chemoattractant cytokines oc-
curred in response to the widest range of stimuli (Figure 2; Table
S1). For example, NOD1/2 & TLR2, TLR2/1 as well as TLR7/8
induced production of TNF-a, IL-1b, IL-8, MCP-1, MIP-1a, and
MIP-1b that was high in the younger age groups, decreasing over
the first year of life to reach adult-low levels around 12 months of
age. TLR3 and TLR9 stimulation on the other hand only led to
production of MCP-1, but followed a similar trend over time.
TLR4 was again the only pathway that displayed opposite trends
in comparison to other PRR. Specifically, TLR4-induced
production of TNF-a, IL-1b, MIP-1a, and MIP-1b all increased
from a low early in life to a high at 12 months of age; IL-8
production in response to TLR4 stimulation was overall low but
higher in the infant as compared to adult samples. MCP-1 was the
only cytokine produced in response to TLR4 stimulation that
followed the more common trend of an early high response
decreasing to an adult low by 12 months of age. Secretion of the
anti-inflammatory cytokine IL-10 occurred only in response to
NOD1/2 & TLR2, TLR2/1 and TLR7/8 stimulation, and
generally decreased from a 2 week high over the first year of life to
reach adult-low levels by 12 months of age.
When comparing the level of PRR induced cytokine secretion
between each successive age group, an increase in the number of
statistically significant differences was detected with increasing age
for all PRR responses except for TLR4 (Table S1). Specifically,
there was no difference in the production of any cytokine between
2 and 6 week old infant samples after NOD1/2 & TLR2
stimulation. Only 2 cytokines (IL-10 and MCP-1) differed
significantly between 6 weeks and 6 months, but 7 cytokines (IL-
10, IL-23, IL-6, MCP-1, MIP-1a, MIP-1b, and TNF-a) displayed
statistically significant differences between the infants’ response to
NOD1/2 & TLR2 stimulation at 6 month and 12 month of age. A
similar increase in the number of significant differences with
advancing age was also observed following TLR2/1, TLR3,
TLR7/8 and TLR9 stimulation. Again, only the response to
TLR4 stimulation did not follow this trend, as cytokine secretion
following TLR4 stimulation did not differ significantly between 2
and 6 week old infants, nor between 6 month and 12 month old
infants, and only 2 cytokines (IL-23 and MIP-1a) differed
significantly between the infants at 6 weeks and 6 months of age.
Single cell analysis of intracellular cytokine production
within the first year of life
To determine the cellular source of key cytokines detected in the
culture supernatant, intracellular cytokine cytometry (ICC) was
employed as previously described [14,16,17,25]. Our panel of
surface anchor markers allowed identification of the major APC
target populations in whole blood (monocytes, B cells, cDC and
pDC, Figures S1 and S2), in parallel to the expression of cytokines
in each of these major APC subsets (Figure S3). A rapid rise in the
fraction of B cells was detected after 2 weeks of age with a slow
decline in the fraction of monocytes over the same time period;
cDC and pDC populations however, remained relatively stable
over the first year of life (Figures S2). Such changes in cellular
composition together with changes in cellular compartments not
analyzed by our flow cytometry-based approach, might affect the
cytokine secretion measured in the culture supernatant described
above, and thus must be considered as a variable during
interpretation of results.
The polychromatic single cell flow cytometric approach enabled
assessment of TNF-a, IL-6, IL-12/23p40 and IFN-a production in
response to PRR stimulation of monocytes, cDC, pDC and B cells.
In this study, B cells did not produce any of these cytokines under
any of the conditions tested (data not shown). Monocytes and cDC
did not respond to TLR3 (pI:C) or TLR9 (CpG) stimulation above
background, while pDC responded to only TLR7/8 (R848) (data
not shown). Therefore, analysis was focused on monocyte and
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cDC responses following stimulation of TLR2 & NOD1/2 (PGN),
TLR1/2 stimulation (PAM), TLR4 (LPS), and TLR7/8 (R848)
(Figures 3, 4 and 5), and on pDC responses, after TLR7/8 (R848)
stimulation (Figure 6). TLR/NOD stimulation of monocytes and
cDC elicited TNF-a, IL-6, and IL-12/23p40 responses, but not
IFN-a, whereas TLR7/8 stimulation of pDC elicited TNF-a, IL-
6, and IFN-a responses, but not IL-12/23p40. Therefore, data
only for the 3 cytokines produced by each respective cell type is
displayed. Visualization of the degree of polyfunctionality (PFD) is
further augmented for each of the innate cell subsets with line
graphs illustrating the proportion of cells producing either 1, 2, or
3 cytokines in response to PRR stimulation. The IL-12 family
Figure 1. Decline in secretion of cytokines promoting either Th1 or Th17 development in South African infants’ whole blood within
the first year of life.Whole blood from subjects enrolled in our longitudinal cohort and sampled at 2 weeks (2 wk; n = 28), 6 weeks (6 wk; n = 26), 6
months (6 mo; n = 23) and 12 months (12 mo; n = 20) of life, and 10 adults (Ad) was stimulated with the indicated TLR ligands and cytokine secretion
into the culture supernatant was measured by Luminex xMAP cytokine assay or by ELISA (IL-23 only). Mean cytokine concentration (pg/ml) is
indicated on the y-axis; error bars indicate SEM. Unstimulated samples displayed cytokine production at very low levels and were subtracted from the
stimulated samples. Cytokines were grouped based on their major known functions, i.e. those promoting either Th1 (IFN-a, IFN-c and IL-12p70 as well
as the IFN-c-induced-protein IP-10), or Th17 development of CD4 T cells (IL-12p40, IL-23, and IL-6).
doi:10.1371/journal.pone.0044763.g001
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members p35, p19, p28 and EBI3 could not be reliably detected
above background by ICC with currently available reagents (data
not shown); only IL-12p40 could be detected as we have previously
described [14,15,16,17]. This precludes differentiation of IL-
12p70 vs. IL-23 by ICC nor could we exclude detection of IL-
12p40 homodimers by ICC.
High level of monocyte and cDC cytokine response to
PRR stimulation decreased over the first year of life for all
pathways except TLR4
Monocytes and cDC displayed an overall very similar response
pattern (Figure 3 and 4). For example, NOD1/2 & TLR2 and
TLR2/1 both induced production of TNF-a, IL-6, or IL-12/
23p40 that was statistically significantly higher in 2 and 6-week
samples as compared the 6 and 12-month infant or adult samples.
While the overall response level to NOD1/2 & TLR2 and TLR2/
Figure 2. Decline of secretion of pro- as well as anti-inflammatory cytokines following PRR stimulation in South African infants’
whole blood within the first year of life. The same samples analyzed in Figure 1 were also analyzed for production of cytokines considered to be
general pro-inflammatory or chemoattractant (TNF-a, IL1-b, IL-8, MCP-1, MIP-1a, MIP-1b) vs. anti-inflammatory (IL-10).
doi:10.1371/journal.pone.0044763.g002
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1 stimulation in monocytes was maintained for the 6-month
samples, cDCs in the same 6-month samples already displayed a
statistically significant decrease to near adult levels. The 12-month
infant samples displayed an overall response to NOD1/2 & TLR2
and TLR2/1 stimulation that was at or near adult responses. For
cDC however, the observed response at 12 months was below the
adult and the other infant age-group responses. The response to
TLR7/8 stimulation resulted in maximal stimulation and this high
level of response was maintained throughout infancy; only cDC in
6 and 12-month samples responded to TLR7/8 stimulation at a
Figure 3. High level of monocyte cytokine response to PRR stimulation decreased between 6 and 12 months of age. Whole blood
samples from neonate-infant subjects were followed longitudinally from 2 weeks (2 wk; n = 28), 6 weeks (6 wk; n = 26), 6 months (6 mo; n = 23) and
12 months (12 mo; n = 20) of life, and 10 adults (Ad) were stimulated with the indicated TLR ligands for 6 h, and intracellular cytokine levels were
measured by flow cytometry for TNF-a, IL-6 and IL12/23p40 gated on monocytes. For each cell type, the total percentage of cytokine-producing cells
is represented by the overall height of bar graphs; color-coded segments constituting the bar allow differentiation of cells producing various cytokine
combinations. Unstimulated samples displayed cytokine production at near 0% and were subtracted from the stimulated samples. (A) Overall stacked
bar graph; statistically significant differences in percent responders are indicated by p-value *,0.05. Cytokine profile – color combinations indicated
in inset in identical order as in bar graphs from top to bottom. (B) Line graphs indicate polyfunctionality degree (PFD) for monocytes, summarizing
the percentage of cells producing 1 (PFD1), 2 (PFD2), or 3 (PFD3) cytokines for each age group.
doi:10.1371/journal.pone.0044763.g003
Figure 4. High level of cDC cytokine response to PAMPs decreased over the first year of life for all stimuli except LPS. Whole blood
samples from ,30 neonate-infant subjects were followed longitudinally from 2 weeks (2 wk; n = 28), 6 weeks (6 wk; n = 26), 6 months (6 mo; n = 23)
and 12 months (12 mo; n= 20) of life, and 10 adults (Ad) were stimulated with the indicated TLR ligands for 6 h, and intracellular cytokine levels were
measured by flow cytometry for TNF-a, IL-6 and IL-12/23p40 gated on cDC. For each cell type, the total percentage of cytokine-producing cells is
represented by the overall height of bar graphs; color-coded segments constituting the bar allow differentiation of cells producing various cytokine
combinations. Unstimulated samples displayed cytokine production at near 0% and were subtracted from the stimulated samples. (A) Overall stacked
bar graph height; statistically significant differences in percent responders are indicated by p-value *,0.05, **,0.01, ***,0.001. Cytokine profile –
color combinations indicated in inset in identical order as in bar graphs from top to bottom. (B) Line graphs indicate polyfunctionality degree (PFD)
for cDC, summarizing the percentage of cells producing 1 (PFD1), 2 (PFD2), or 3 (PFD3) cytokines for each age group.
doi:10.1371/journal.pone.0044763.g004
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level statistically significantly below that of the 6 week old samples.
The response pattern of monocytes and cDC to TLR4 stimulation
again displayed a different pattern compared to all other stimuli:
while all infant samples revealed a higher overall response as
compared to adult samples, the maximal response to TLR4
stimulation was detected in the 6 month samples for both
monocytes and cDC; this peak at 6 months however was not
significantly different as compared to either the 6 week or the 12
month samples.
Despite the similarities in response to NOD1/2 & TLR2 and
TLR2/1 stimulation, we detected substantial differences in the
combination of the particular cytokines produced (Figure 3 and 4).
While TNF-a-only producing monocytes and cDC represented
the major population of responders to both NOD1/2 & TLR2
and TLR2/1 stimulation, TLR2/1 stimulation induced a larger
fraction of IL-6- or IL-12-only producing cells as compared to
NOD1/2 & TLR2 stimulation. Both NOD1/2 & TLR2 and
TLR2/1 stimulation also induced a substantial fraction of cells
that produce both, TNF-a and IL-6 as well as monocytes and cDC
producing all three cytokines. These trends were also clearly
evident in the PFD line graphs for NOD1/2 & TLR2 and TLR2/
1 stimulation for both monocytes and cDC. TLR7/8 stimulation,
however, induced the largest fraction of monocytes and cDCs
producing all three cytokines, that in cDC reached and in
monocytes even surpassed the fraction of cells producing only 1 or
any 2 cytokines.
The level of expression per cell (i.e. the mean fluorescent
intensity, or MFI) of IL-12 in monocytes and cDC decreased in
response to every stimulus from a 2 week old high to and adult-low
by 12 months of age (Figure 5). While a similar trend was observed
for the MFI of IL-6 in monocytes and cDC in response to NOD1/
2 & TLR2, TLR2/1 and TLR7/8 stimulation, the IL-6 MFI
increased again in monocytes from a 6 week low. For the TNF-a
MFI in monocytes and cDC our findings suggest an overall similar
level of expression per cell across all age groups in response to
NOD1/2 & TLR2, TLR2/1 and TLR7/8 stimulation, and even
an increase from 2 weeks to 12 months in response to TLR4
pathway activation.
pDC cytokine production in response to PRR stimulation
remained high throughout the first year of life
The fraction of pDC responding to TLR7/8 stimulation was
similar in all age groups we tested, both in overall response as well
as cytokine-combination specific subsets (Figure 6A). For example,
the largest fraction of pDCs were positive for both TNF-a and
INF-a, followed by cells positive for INF-a only. This was also
Figure 5. Mean fluorescence intensities (MFI) of monocyte or cDC cytokine production drastically fell over the first year of life for
all cytokines except TNF-a and IL-6 in response to LPS stimulation. Whole blood samples from ,30 neonate-infant subjects were followed
longitudinally from 2 weeks (2 wk; n = 28), 6 weeks (6 wk; n = 26), 6 months (6 mo; n = 23) and 12 months (12 mo; n = 20) of life, and 10 adults (Ad)
were stimulated with the indicated TLR ligands for 6 h, and intracellular cytokine levels were measured by flow cytometry for TNF-a, IL-6 and IL-12/
23p40 gated on monocytes (blue line) and cDC (red line). The MFI values from all samples of each age group were averaged after first excluding the
samples that had cytokine-positive percentage ,4% of the APC subtype. Means for each population were derived from the FlowJo software; error
bars indicate SEM.
doi:10.1371/journal.pone.0044763.g005
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reflected in the line graph displaying PFD (Figure 6B). However,
while the level of expression of INF-a per cell decreased from a 2
week high to a 12 month low, the MFI for TNF-a decreased from
a 2 week high to a 6 month low, only to increase again by 12
months of age (Figure 6C).
Discussion
This is the first longitudinal cohort study analyzing human
innate immune ontogeny over the first year of life in a developing
nation, and complements similar themed cross-sectional studies
from resource poor settings in The Gambia [21], Ecuador [23],
and Papa New Guinea [22]. Several well-characterized PRR
ligands were used to stimulate whole blood samples collected in the
same cohort of infants at 2 and 6 weeks, 6 and 12 months of age
and compared to adult samples according to a robust innate
immune profiling platform. A striking decrease from an early high
to an adult low by 12 months of age was detected for nearly all
cytokines analyzed in response to nearly all stimuli. Specifically,
cytokines promoting Th1 or Th17 development such as IFN-a,
IFN-c, IL-12p70 or IL-23 and IL-6 decreased from a high in the
first half-year of life to an adult low by 12 months of age. We
observed the same age-dependent trend in response to PGN
(NOD1/2, TLR2), PAM (TLR2/1), pI:C (TLR3) or R848
(TLR7/8) stimulation for the proinflammatory cytokines or
chemoattractants (TNF-a, IL-1b, IL-8, MCP-1, MIP-1a and
MIP-1b) as well as the anti-inflammatory IL-10. Only the response
to TLR4 stimulation with LPS did not follow this trend, in that
production of IL-23, IL-6, TNF-a, IL-1b, MIP-1a, MIP-1b either
increased from an early low to a high at 12 months of age or
maintained a higher than adult production throughout the first
year of life (e.g. IL-8). LPS (TLR4) induced MCP-1 production
was the only response that followed the more common age-
dependent decline from an early high to an adult-low by 12
months of age. Singe-cell intracellular cytokine cytometry overall
confirmed the secreted cytokine pattern, in that PGN (NOD1/2,
TLR2), PAM (TLR2/1) and R848 (TLR7/8) stimulation of
monocytes and cDC led to production of TNF-a, IL-6 and IL-12/
23p40 that decreased from an early high to a low by 12 months of
age. Again, only the response of monocytes and cDC to LPS
(TLR4) followed the opposite direction of the more common age-
dependent trend. The percentage of pDC responding to TLR7/8
(R848) stimulation with INF-a and TNF-a expression remained
relatively constant throughout infancy. The level of expression of
each cytokine per cell, i.e. the mean fluorescent intensity,
reinforced these findings as only expression of TNF-a per cell
remained relatively constant in all cell types across the infant age
groups.
The unique pattern of increasing sensitivity to TLR4 stimula-
tion over the first year of life is supported by previous observations
that cord blood was poorly responsive to LPS as compared to
adults [26]. However, the underlying mechanisms that led to the
Figure 6. The fraction of pDC producing cytokines in response to PAMPs remained high throughout the first year of life, but the
MFI for INF-a decreased. Whole blood samples from ,30 neonate-infant subjects were followed longitudinally from 2 weeks (2 wk; n = 28), 6
weeks (6 wk; n = 26), 6 months (6 mo; n = 23) and 12 months (12 mo; n = 20) of life, and 10 adults (Ad) were stimulated with the TLR7/8 agonist R848
for 6 h, and intracellular cytokine levels were measured by flow cytometry for TNF-a, IL-6 and INF-a gated on pDC. Unstimulated samples displayed
cytokine production at near 0% and were subtracted from the stimulated samples. (A) Overall stacked bar graph height indicates the total
percentage of pDC producing one of the measured cytokines. Overall responses were broken down by cytokine expression profile and were coded
by color (cytokine profile – color combinations indicated in inset in identical order as in bar graphs from top to bottom). (B) Line graphs indicate
polyfunctionality degree (PFD) for cDC, summarizing the percentage of cells producing 1 (PFD1), 2 (PFD2), or 3 (PFD3) cytokines for each age group.
(C) Line graphs indicate the mean fluorescent intensity (MFI) in the respective sample for INFa and TNF-a. The MFI values from all samples were
averaged after first excluding the samples that have cytokine-positive percentage ,4%. Means for each population are derived from the FlowJo
software; error bars indicate SEM.
doi:10.1371/journal.pone.0044763.g006
Early Life Innate Immune Ontogeny
PLOS ONE | www.plosone.org 7 September 2012 | Volume 7 | Issue 9 | e44763
divergent trends for LPS vs. other PAMPs is currently unclear.
Further investigation correlating PAMP responses and suscepti-
bility to infectious morbidity from e.g. Gram negative (via TLR4)
versus viral (via e.g. TLR3) may yield valuable information.
Given the changes in cellular composition of WB over the first
year of life (Figure S1), it is difficult to interpret age-associated
changes of cytokine levels detected in culture supernatants. Our
previous study in North America and this current study in South
Africa represent the first cohort studies to attempt identifying the
cellular source of cytokines detected in supernatants extending and
complementing previous studies of innate immune ontogeny
which only performed secreted cytokine analysis [18,19,21]. We
had demonstrated in prior experiments, that multiplex bead array-
based analysis is largely congruent with ICC, but does not always
produce the exact same pattern of cytokine expression as ICC
analysis [17,27]. The comparison of intracellular and secreted
cytokine production allows contextualization of cellular responses
and provides a comprehensive approach to describing innate
immune ontogeny. While the trends we observed in our South
African cohort in innate immune responses evaluated by ICC and
multiplex bead array were the same, the magnitude of the change
in response with age was much less apparent by ICC than by
multiplex bead array. For example, the level of TNF-a detected in
culture supernatant in response to TLR2/1 stimulation decreased
dramatically between 6 months and 12 months of age (Figure 2),
while the number of cells that produced of TNF-a in response to
PAM actually remained steady (Figure 3 and 4) and in fact
increased on a per cell basis (MFI, Figure 5). This suggests that
either cellular sources were involved in cytokine production that
we did not assess by flow cytometry (e.g. NK, NKT, or cd-T cells),
or that cell-cell interactions and responses to secreted cytokines
were inhibited by the secretion inhibitors used in the experimental
set up for flow cytometry. Both of these hypotheses can be
interrogated by expanding the range of target cells for ICC and a
time course of addition of cytokine secretion inhibitors. We were
unable to detect our target cytokines in B cells in response to
PAMP stimulation, which confirms previous findings [17], but
stands in contrast to data from animal studies [28], which
demonstrated cytokine production from marginal zone and
follicular B cells in response to TLR stimulation. This may
indicate differing responses in white blood cells in peripheral blood
vs. tissue resident cells or differences between humans vs. mice.
Our detailed, broadly functional as well as single-cell based
analysis of early life innate immune ontogeny adds insight into
human innate immune development by demonstrating dynamic
changes of innate immune reactivity specific to age, stimulus and
cytokine response. These data also provide the first suggestion of
population-specific differences in innate immune development:
Contrary to our findings presented here on innate immune
ontogeny in South African infants, we had previously detected an
increase rather than a decrease from birth up to 2 years of age in
Th1 and pro-inflammatory cytokine production following TLR
stimulation in infants born and raised in North America [17]. A
recent study investigating TLR polymorphisms within a South
African population, and the resulting heterogeneity of immune
responsiveness to TLR stimulation [29], lends some support to our
observation of population specific differences in innate immune
responsiveness.
Our studies on North American infants had been conducted on
peripheral blood mononuclear cells (PBMC) instead of whole
blood (WB), which can lead to significant differences in responses
as we have shown [15]. Furthermore, our previous studies did not
include infant age groups between birth and 1 year of age, and
thus are difficult to directly compare with this current study. Our
previous results with North American infants were however in line
with studies of European or Papa New Guinean infants that used
whole blood and followed infants throughout the first year of life
[18,19,22]. Specifically, both Nguyen et al. [18] and Belderbos et
al. [19] detected an increase in LPS or CpG induced INFc, IP-10
and IL-12p70 production over the first year of life in European
infants. This stands in sharp contrast to our South African cohort,
where we detected either no response or a decrease over time
(Figure 1).
This striking difference between North American and European
vs. South African infant innate immune ontogeny suggests that
differences between resource-rich vs. resource-poor countries
might play a role in development of the innate immune system.
Comparing the results of our current study with South African
infants to those of Burl et al. [21] who studied the TLR response of
infants born and raised in The Gambia, we indeed found them to
be mostly similar. For example, the trend for TNF-a responses
over the first year of life following stimulation with TLR2/1,
TLR4 and TLR7/8 was nearly identical to ours. However, the
study by Burl et al. was cross-sectional in nature, and progressive
changes in innate immunity over the first year of life could thus
have been influenced by inter-individual variability [24]. A similar
decline consistent with our findings and those of Burl et al. in TLR
induced cytokine production in whole blood was also detected in
children born and raised in Ecuador; this decline was observed
between 1 and 2 years of age, with no information provided about
the earlier time points [23]. However, such decline was not
observed in a recent study of infants in Papa New Guinea [22].
Together, this data supports the notion that different develop-
mental trajectories of innate immune ontogeny exist for infants
from different regions of the world. Given the heterogeneity of
innate immune development within a given population [29], and
the many variables that can influence innate immune analysis
[15], this hypothesis will have to be tested in a well-controlled,
direct side-by-side comparison.
There are several possible mechanisms that might contribute to
differences between European and North American infants on one
side, and infants from South Africa, The Gambia, Ecuador and
Papa New Guinea on the other. One possibility is related to the
receipt of live vaccines around birth. For example, none of the
infants in either Europe or North America received either BCG or
oral polio vaccine (OPV) at birth, while children in both South
Africa and The Gambia received both BCG and OPV at birth.
The infants in the study from Papa New Guinea received BCG at
birth, but were mixed with respect to a neonatal dose of oral polio
vaccine; and infants in the study from Ecuador receive only BCG
at birth. The similarities between our South African study and the
Gambian study by Burl et al. or the Ecuadorian study by Teran et
al. and the Papa New Guinean study by Lisciandro et al. also raise
the possibility that differences in host genetics and/or differences
in exposure to environmental stimuli other than vaccines might
influence innate immune ontogeny. Differences in early life
environmental exposure associated with atopic disease in Austra-
lian children have been shown to lead to an innate immune
development more akin to the trajectories we detected in South
African infants [30]. And differences in innate cytokine production
have been described for the same ethnic groups living in different
environment [31]. On the other hand, differences in ethnicity (and
by extrapolation host genetics) are known to lead to different
innate immune responses to malaria infection in children in West
Africa [32], suggesting differences in host genetics between South
African and e.g. North American or European infants could
equally be important in our findings [33]. As such, evaluation of
European-descent vs. African-descent or affluent vs. poor South
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African infants may generate different results. The diversity of
South African demographics provide a unique opportunity to
investigate the precise role of genetics vs. early life live-exposures
(including vaccines) on innate immune development. Irrespective
of the role of impact of live vaccination, and/or genetics vs.
environment, the currently available data strongly suggest that
differences in innate immune ontogeny early in life between
children born and raised in different regions of the world exist.
How such differences impact protection from infection or response
to vaccination represents an exceptionally important issue to
address.
As we had done in our previous studies in Canada [16,17], we
also included ethnically-matched adults as controls in our South
African study, with the aim of providing a stable comparator for
the developing innate immune ontogeny. Comparing results of
WB responses following PRR stimulation between North Amer-
ican adults to South African adults, a strikingly lower response was
noted for all stimuli and all cytokines in the South African
compared to North American adults. European Caucasian adult
controls similar to our Canadian adults also appear more
responsive to PRR stimulation than South African adults
[18,19]. It would possibly be informative to decipher how different
innate immune trajectories relate to overall immune senescence
[34]. While it is tempting to speculate that the trajectory we
observed in South African infants to reach adult-like low
responsiveness by 12 months of age could be a general difference
between resource-rich vs. resource-poor settings affecting all age
groups, and possibly relate to the higher infectious morbidity and
mortality across all age groups in resource-poor vs. resource-rich
regions of the world, this hypothesis will need to be directly tested.
Infant morbidity and mortality from infectious disease are
highest during the first year of life [35], identifying the first 12
months of life as the most critical period to induce protection from
pathogens through vaccination [2]. Contrasting our findings to our
previous studies in North America, others from Northern Europe,
and those from Africa, South America or the Pacific Islands, it is
likely that differences in innate immune ontogeny early in life exist
in different populations. Based on our current findings, this may in
fact apply not only to early but also to adult life. The underlying
mechanisms for these striking observations are not yet known. Our
data strongly argue that innate immune development is highly
heterogenic across the globe, suggesting that strategies aimed at
preventing infection through e.g. vaccination might benefit if
tailored to the specific target population.
Materials and Methods
Ethics Statement
This study was specifically approved by the Research Ethics
Committee of Stellenbosch University and the IRB of the
University of British Columbia (Protocol H09-02064 and H11-
01947). Informed written consent from the next of kin, care givers
or guardians on the behalf of the minors/children participants
involved in our study was obtained for all study participants.
Prospective Birth Cohort Study Design
A prospective, longitudinal cohort study commenced in 2009 in
Cape Town, South Africa, to evaluate immune function in infants
early in life. Infants were recruited at birth at the Tygerberg
Academic Hospital (TAH) labor ward. Mothers’ HIV-negative
infection status was confirmed on presentation at TAH using
serological HIV testing algorithms according to South African
national protocol [36]. Infants were excluded from the study if any
of the following criteria were met at any of time of the study: (1)
The diagnosis of a significant chronic medical condition including:
immunosuppression by disease or medication; cancer; bone
marrow or organ transplantation; blood product administration
within the last 3 months; bleeding disorder; known congenital
malformation or genetic disorder; (2) If the parent or legal
guardian were unable to read and/or comprehend the consent
process. Additionally, any febrile illness within the last 24 h, or
brief (,1 months) immunosuppressive medication use within one
month, would result in a deferral of the blood draw to a later date.
Fifty-four percent of enrolled subjects were male; the mean
gestational age of enrolled infants in weeks was 37.9 (37.0–38.7
CI), and the mean birth weight in grams was 2986 (2830–3142
CI). Infants were followed at 0.5, 1.5, 3, 6, and 12 months (3
month innate responses were not analyzed). We initially enrolled
29 infants and were able to analyze 28 of them at 0.5 months (one
infant did not provide a blood sample), 26 at 1.5 months, 23 at 6
months and 20 at 12 months. We were unable to locate and
contact the 8 infants that were lost to follow up over the first year
of life. Infants received their vaccinations according to South
Africa’s Expanded Program for Immunization (EPI). At each visit,
infant health history was obtained, receipt of immunizations on
the infant immunization card verified, and physical examinations
conducted by medical professionals. The median duration of
exclusive breastfeeding was 12 weeks. Healthy adults, unrelated to
the infants, aged 24 to 47, of equal male-female ratio and ethnic
background as the infant study subjects were recruited at
Stellenbosch University.
Blood sample processing
All blood draws were performed in the hospital by a trained
phlebotomist. 3–5 ml of peripheral blood was drawn via sterile
venipuncture into Vacutainers containing 143 USP units of
sodium-heparin (Becton Dickinson (BD) Biosciences, catalog
no. 8019839) using batches we had previously confirmed to be
free of innate immune activating substance in assays performed as
described elsewhere [14]. Blood samples were kept at room
temperature and processed within ,4 hours of the blood draw as
described previously [14,15]. Infant or adult peripheral blood was
mixed with 37uC pre-warmed RPMI 1640 at a ratio of 1:1. Two
hundred microliters of diluted blood was added to each well of the
premade plates containing the specific PAMPs at a concentration
that elicited most pronounced responses without indication of
toxicity [25,37]. Cells were stimulated with either nothing, or
PGNSA (TLR2, NOD1/2; InvivoGen) at 1 mg/ml, PAM3CSK4
(TLR2/1, EMC microcollections) at 1 mg/ml; poly I:C (TLR3,
Amersham) at 50 mg/ml; 0111:B4 LPS (TLR4, InvivoGen) at
10 ng/ml; R848 (TLR7/8, InvivoGen) at 10 mM; CpGA (TLR9,
Coley) at 25 mg/ml.
For the ICS assays, cells were incubated for 6 h at 37uC in 5%
CO2. For the TLR3 and TLR9 ligands, BFA was added after 3 h,
providing optimal detection of intracellular cytokine production in
response to these ligands [14]. After culture, cells were treated with
a final concentration of 2 mM EDTA for 15 min at 37uC, then
spun down and resuspended in 100 ml of 16 BD FACS Lysing
Solution, sealed, and stored frozen at 280uC until staining. An
identical set of plates was incubated in parallel for 18 h without
BFA; at 18 h, these plates were spun and 100 ml of supernatant
was removed and frozen at 280uC for later Luminex analysis.
Assessment of cytokines in culture supernatant
Supernatants were thawed at room temperature, and filtered
through a 1.2-mm filter plate (Millipore) into a clean 96-well plate
to remove any remaining cellular debris using a multi-screen HTS
vacuum manifold (Millipore). The Luminex assay was performed
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using the Upstate/Millipore ‘‘Flex Kit’’ system using the high-
biotin protocol and overnight incubation at 4uC. Cytokines
measured were IFN-a2, IFN-c, IP-10, IL-12p70, IL-12p40, IL-
6, TNF-a, IL-1b, IL-8, MCP-1, MIP-1a, MIP-1b, IL-10. Samples
were diluted 1-to-1 (10- or 20-fold if needed to fall within the
standard curve) with RPMI 1640 supplemented 10% human AB
serum. Assays were read using Luminex 200 Total System
(Luminex) running either the Bio-plex (Bio-Rad) or the MasterPlex
(MiraiBio) softwares, and the downstream analysis was performed
using Excel (Microsoft) and an in-house database. To determine
the IL-23 concentration, filtered supernatants were diluted 1:4 in
diluent contained in the human IL-23 (p19/p40) ELISA kit
(eBioscience), and assays were performed according to the
manufacturer’s specifications. Plates were read at 450 nm with
570-nm subtraction. A sigmoid logistic curve was used to generate
the standard curve. The responses observed in the unstimulated
(negative) controls were negligible for all subjects, and subtracted
from the stimulated samples for each individual.
Staining, acquisition, and flow cytometric analysis
Preparation of the samples for flow cytometric analysis was
performed as described previously [14,25,37]. A detailed descrip-
tion of antibodies (source, clone, and dilution), machine set up,
and data acquisition compliant with the recently accepted
MiFlowCyt reporting standards [25,38] can be found in the Text
S1. Briefly, frozen plates were thawed and spun, and pellets were
resuspended in 200 ml of BD FACS Permeabilizing Solution and
incubated at room temperature for 10 min. After one wash in PBS
containing 0.5% BSA and 0.1% sodium azide (PBSAN), cells were
stained in a final volume 100 ml of PBSAN for 30–60 min at room
temperature. After two additional washes with PBSAN, cells were
resuspended in PBS containing 1% paraformaldehyde and
immediately analyzed on an LSRII Flow Cytometer (BD
Biosciences) set up according to published guidelines [14,25,39].
Compensation beads (CompBeads; BD Biosciences) were used to
standardize voltage settings and used as single-stain positive and
negative controls as described previously [14,25,40]. Frozen stock
of one adult WB sample stimulated with R848 was used to set up
the detectors in every run to ensure MFI of cytokine positive and
negative populations remained approximately the same. A total of
500,000 events were acquired per sample. Compensation was set
in FlowJo (Tree Star) and samples were analyzed compensated.
Gates were set based on the fluorescence-minus-one principle
[41,42]. We positioned the unstimulated flow cytometric samples
as a biological negative control, and any cells producing cytokine
above the cutoff in the negative controls were subtracted from the
stimulated sample responses. This has been identified as the most
appropriate approach for flow cytometric analysis of stimulation
experiments [42].
Statistical analysis
Graphs were prepared using Excel (Microsoft). Statistical
differences between infant pairs were analyzed using the Wilcoxon
matched-pair signed rank test. To correct for multiple compar-
isons of the secreted cytokine analysis, we computed the
Bonferroni corrected acceptable Type I error rate (alpha) as
0.05/6 stimulation conditions = 0.01 (0.0083), as these would yield
false discoveries at a rate of ,0.05 (for a total of 6 comparisons for
each data set) [43]. Accordingly, p-values of ,0.01 were
considered significant. To assess polyfunctionality (i.e., the ability
of an individual cell to produce one vs. more than one cytokine in
response to a specific stimulus), we computed the percentage of
cells in a given cytokine-combination category (e.g., there are 7
possible cytokine-combination categories for 3 cytokines in which
at least one cytokine is positive (23–1= 7)). The percentages of
reactive cells that were positive for only one of the 3 cytokines were
added up to give the polyfunctional degree (PFD) 1 (PFD1); and
separately, the percentages of reactive cells expressing any 2 of the
3 cytokines or all 3 cytokines were computed to give PFD2 and
PFD3 values, respectively. Given that values of polyfunctional
subsets in flow cytometry represent qualitative composites of
several categories of quantitative data, and statistical analysis
would thus be of little value, the flow cytometric analysis of
polyfunctional cytokine production was not subjected to statistical
examination.
Supporting Information
Figure S1 Gating strategy for antigen-presenting cell
subsets in WB. The gating strategy to identify innate immune
cell subsets was as follows: monocytes (MHCII+, CD14+/high),
conventional DCs (MHCII+, CD142/low, CD1232, CD11c+),
plasmacytoid DCs (MHCII+, CD142, CD11c2, CD123+), and B
cells (MHCII+, CD142, CD11c2, CD1232).
(TIF)
Figure S2 Antigen-presenting cell subsets in WB. Relative
percentage of WB cell APC populations gated on mononuclear
cells in samples from 2 weeks, 6 weeks, 6 months and 12 months of
life, and 10 adults. Error bars indicate SEM.
(TIF)
Figure S3 Flow Cytometric analysis of cytokine produc-
ing cell subsets in WB. As an example to illustrate flow
cytometry based cytokine assessment over the first year of life and
contrasted to adult control, an overlay is used to compare the
unstimulated sample (blue) with the sample stimulated (red) with
the TLR7/8 ligand, R848.
(TIF)
Table S1 Increasing number of significant differences
in the level of cytokine secretion following PRR stimu-
lation with increasing age. Whole blood from subjects
enrolled in our longitudinal cohort and sampled at 2 weeks
(2 wk; n= 28), 6 weeks (6 wk; n= 26), 6 months (6 mo; n= 23) and
12 months (12 mo; n= 20) of life was stimulated with the indicated
TLR ligands and cytokine secretion into the culture supernatant
was measured by Luminex xMAP cytokine assay or by ELISA (IL-
23 only). Differences in mean cytokine concentrations between 2
successive age groups (2 vs. 6 weeks; 6 weeks vs. 6 months; 6 vs. 12
months) were compared using the Wilcoxon matched-pair signed
rank test, and corrected for multiple comparisons. A corrected p-
value of less than 0.01 indicates a significant difference
(highlighted in yellow).
(XLS)
Text S1
(DOCX)
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